
Tablet · 1.25 mg (1-2.5 mg range)

An evidence-supported oral therapy for female-pattern hair thinning — improves scalp perfusion and hair density at doses far below blood-pressure levels. Reassessed at 3–6 months.


Answer a few health questions — a licensed provider reviews online. No waiting rooms.

Once approved, your medication ships discreetly to your door.


Physician-guided support and check-ins keep results on track.

Take 1 tablet by mouth daily; assess response at 3-6 months
Read this before you start. The only FDA approved oral minoxidil is for severe high blood pressure, at doses many times higher than the dose used for hair. That label carries a boxed warning for fluid building up around the heart, which can become dangerous, and for worsening chest pain. Hair loss dosing is far lower and no FDA approved product exists at that dose, so the risk at this dose has not been established. Your clinician reviews your heart history before prescribing it.
Oral minoxidil is not approved for hair loss at any dose. Using it this way is off-label, which means the FDA has not reviewed it for this purpose.
Tell your care team straight away if you get chest pain, shortness of breath or trouble lying flat, a racing heartbeat, sudden weight gain or swelling in your hands, feet or face, or you faint.
Common side effects
Rare but serious
Do not take this if you have a pheochromocytoma, or you have reacted badly to minoxidil before.
This is not a complete list of side effects. Message your care team about any symptom that worries you. What we dispense is a compounded preparation made by a licensed US pharmacy. Compounded medications are not approved by the FDA for safety, efficacy or quality.
Low-dose oral minoxidil avoids the daily mess, scalp irritation and application routine of topical treatment, and some people who did not respond to topical do respond to oral. It is prescribed off-label for hair loss at doses far below those used for blood pressure.
Reduced shedding often comes first at around three months, with visible thickening typically between six and twelve months.
Unwanted hair growth elsewhere — face, arms — is the most common and is dose-related. Fluid retention, ankle swelling, dizziness and a faster heart rate are also reported. Tell your clinician about any of these.
Yes. A temporary increase in shedding in the first weeks is common as follicles shift into a new growth cycle. It is not a sign the treatment is failing.

Globally recognized aging biologist and former CEO of the Buck Institute for Research on Aging, renowned for pioneering research on sirtuins, mTOR, and healthy aging.

World-leading biogerontologist and Founding Director of the Healthy Aging & Longevity Research Institute, celebrated for uncovering the biological mechanisms of aging.

Board-certified Family Nurse Practitioner with 15+ years of clinical experience, specializing in preventative wellness and biomarker-driven personalized care.